SumFlex 2025 in Mumbai Ignites India’s $100 Billion Nutraceutical Ambition

Mumbai, May 12, 2025 – The NutrifyToday C-Suite SumFlex 2025, held in Mumbai, has positioned itself as the most influential catalyst in India's journey to becoming a global nutraceutical superpower. The summit convened top leadership across pharmaceuticals, nutrition science, venture capital, and policy, all aligned to a unified mission: to scale India's nutraceutical industry to USD 100 billion by 2047.

The precision-led gathering drew delegates from the United States, South Korea, Malaysia, and other nations, bringing strategic clarity to India's place in the global wellness economy.

“SumFlex was not just an event — it was a declaration of intent,” said Amit Srivastava, Founder of Nutrify Today.
“It is time India moves from being the world's nutraceutical factory to becoming its innovation and integrity capital. This is more than business — it's a legacy in motion.”

India’s Nutraceutical Moment Mirrors America’s Breakout Era

Industry leaders and policymakers believe India is in the midst of a transformation akin to what the United States experienced in the early 2000s, when the nutraceutical sector crossed the USD 15 billion threshold. Today, India stands at USD 18 billion (2023), with a 13.5% CAGR, as per Invest India.

With initiatives like Project One Future, India is integrating its rural economy into the USD 3 trillion global food and nutrition supply chain, giving shape to a truly inclusive and scalable growth strategy.

“India is no longer just a backend producer,” said Dr. Anand Swaroop, President of Cepham USA.
“We are watching India emerge as the epicentre of responsible, science-driven nutrition for the world.”

Policy Push: Empowering Rural India for Global Wellness

A significant development came with the announcement of an MoU between India Chambers and the Rural Economic Forum, introduced by Dr. Nitin Pangotra, Advisor to the MSME Ministry. The collaboration will enable rural innovators and micro-enterprises to plug directly into the high-value global nutraceutical supply chain — from farm to finished product.

India’s Pharma-Nutra Convergence: Titans at the Table

SumFlex 2025 brought together C-level leaders from India’s top pharma and nutra companies:

Shivam Puri, MD & CEO, Cipla Health

Ganesh Nayak, Executive Director, Zydus Group

Amal Kelshikar, Executive Director, Torrent Pharma

Dipanjan Basu, Co-founder & Partner, Fireside Ventures

Anil Matai, President, OPPI

Shantaprasad Nagarmath, CEO, Dr. Reddy’s & Nestlé Health Science Ltd.

Sanjaya Mariwala, Executive Chairman, Omniactive Health

Saif Mekhri, CEO, BiogenExtracts

Suresh Garg, MD, Zeon Lifesciences

Tim Opler, Managing Director, Stifel

William Hood, Managing Director, William Hood & Company

Heather Wainer, Chief Business Officer, WholeFoods Magazine

Dr. Bharat Shah, Chief Nephrologist, Gleneagles Hospitals

Dr. Narendra Malhotra, MD, Ujala Cygnus Rainbow Hospitals

Strategic sessions revolved around mergers & acquisitions, commercializing novel actives, and AI-enabled licensing platforms — including the unveiling of Dealsphere.NutrifyToday.com, the first-of-its-kind digital tool enabling product commercialization in just 15 days.

Launchpad for Global Products and Scientific Tools

The summit also served as a launch platform for responsible, science-backed innovation.

Dr. Reddy’s and Nestlé Health Science introduced Celevida Diafiber, a product designed for metabolic health — showcasing the C-Suite as a trusted space for serious product debuts.

Another major launch was Rx.NutrifyToday.com, the world’s first digital reference tool for doctors to verify nutraceutical ingredients and health claims. While currently public, its next version (Oct 2025) will offer doctor-only access to ingredient safety, toxicity, and mechanisms of action.

Beyond Optics: RoI-Driven Networking

The summit's format focused on value over vanity. With tight curation and purpose-built programming, every panel, pitch, and interaction was aligned to industry outcomes and long-term value. Attendees engaged in deep, high-stakes dialogue with measurable follow-through.

“C-Suite SumFlex 2025 has redefined how business summits are measured. This was about strategic RoI — not footfall,” noted one investor attendee.

India’s Moment to Lead

SumFlex 2025 has set a new bar for India’s leadership in the wellness economy.

“We’re not chasing trends. We’re shaping a new global model of responsible nutrition,” said Amit Srivastava.
“This is India’s moment. And we’re owning it with purpose.”